Refine Search

  •  
  •  
Companies reject partnership

NEW YORK -- British drug maker SmithKline Beecham PLC said late Monday that it failed to agree on terms to combine with Glaxo Wellcome PLC in what would have been the biggest corporate...

http://chronicle.augusta.com/stories/1998/02/24/bus_223045.shtml
Business
Merck drags down drug stocks

...cautionary note put investors off of the traditionally market-beating drug sector. As earnings for Merck and SmithKline Beecham PLC disappointed investors, Schering-Plough Corp. slightly beat analysts' early expectations, and American Home...

http://chronicle.augusta.com/stories/1998/07/22/bus_233965.shtml
Business
Beecham plans to add jobs

...he said. "Oxy will then be moved to our facility." SmithKline Beecham Corp. is the chief subsidiary of SmithKline Beecham PLC of Middlesex, England. The Philadelphia-based company had annual sales of $4.9 billion in 1994 and employed...

http://chronicle.augusta.com/stories/1996/08/13/met_199171.shtml
Metro
Pfizer makes offer for Warner-Lambert

...billion in sales in 2002. American Home tried twice to find a partner last year, but negotiations fell apart with SmithKline Beecham PLC and later with Monsanto Co. Warner-Lambert also has been looking for partners to expand its business. Earlier...

http://chronicle.augusta.com/stories/1999/11/05/bus_272663.shtml
Business
Diabetes drug Rezulin will survive federal restrictions

...the disease progresses. They may soon get them. Next month, an FDA advisory panel will review Avandia from SmithKline Beecham PLC and Actos from Eli Lilly & Co. and Takeda Chemical Industries Ltd. Analysts say the drugs may face more scrutiny...

http://chronicle.augusta.com/stories/1999/03/30/tec_257712.shtml
XXX Technology
Pill, toy top list of year's best

...balm was left waiting at the altar twice. In February, American Home discussed merging with British drug maker SmithKline Beecham PLC. But SmithKline backed out in favor of talks with Glaxo Wellcome PLC, which were later aborted. In October...

http://chronicle.augusta.com/stories/1998/12/27/bus_248480.shtml
Business
Additional area business news

...to comment on whether the case is linked to unusual price drops late Friday in shares of Glaxo Wellcome Plc and SmithKline Beecham Plc that raised the specter of market manipulation. Glaxo Wellcome's share price fell $1.53 to $21.62 and...

http://chronicle.augusta.com/stories/1997/12/02/biz_218376.shtml
XXX Bizarre
Additional area news

...to comment on whether the case is linked to unusual price drops late Friday in shares of Glaxo Wellcome Plc and SmithKline Beecham Plc that raised the specter of market manipulation. Glaxo Wellcome's share price fell $1.53 to $21.62 and...

http://chronicle.augusta.com/stories/1997/12/02/biz_218377.shtml
XXX Bizarre
FDA weighs approval of antidepressants for kids

...in sales in 1995. Eli Lilly sent the FDA test data in December. Pfizer Inc. has submitted data on Zoloft, SmithKline Beecham PLC is conducting tests of Paxil, and Bristol-Myers Squibb Co. and American Home Products Corp. are preparing...

http://chronicle.augusta.com/stories/1997/05/01/ent_207579.shtml
Things to Do
Hostile takeovers thrive as stocks hit record highs

...Energy Group. And the British press has reported that Glaxo Wellcome is weighing a possible hostile offer for SmithKline Beecham PLC after the breakdown of an earlier, negotiated agreement to combine in what would be the biggest merger ever...

http://chronicle.augusta.com/stories/1998/03/08/bus_223710.shtml
Business